Results 31 to 40 of about 1,048,158 (273)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2 [PDF]

, 2020
The rapid transmission of SARS-CoV-2 through the world has induced the scientist to understand the histopathology of the virus and then to find an effective drug.
Al-Gheethi, Adel, Al-Shorgani, Najeeb, Hezam, Kamal, Noman, Efaq, Othman, Norzila, Radin Mohamed, Radin Maya Saphira, Talip, Balkis   +6 more
core  

Therapeutic antibodies under development for SARS‐CoV‐2

View, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu   +7 more
doaj   +1 more source

Aptamer‐based strategies against SARS‐CoV‐2 viruses

BMEMat, 2023
The COVID‐19 pandemic, caused by SARS‐CoV‐2, has seriously threatened human life and security in recent years and has had a serious impact on economic development. A range of strategies, including antibodies, small‐molecule agents and vaccines, have been
Yihao Huang, Ximing Chen, Jialu Zhang, Wenhai Tian, Siwen Liu, Rachel Chun‐Yee Tam, Chaoyong Yang, Yanling Song   +7 more
doaj   +1 more source

Survival and disinfection of SARS-Cov-2 in environment and contaminated surface [PDF]

, 2020
The detection of SARS-Cov-2 in the sewage and water resources has increased the awareness among the people about the possibility survival of SARS-Cov-2 in the environment and the potential to transmit into the human through food chain or water resources.
Al-Gheethi, Adel, Al-Maqtari, Qais, Almoheer, Reyad, Hamdan, Rafidah, Noman, Efaq, Radin Mohamed, Radin Maya Saphira   +5 more
core  

COVID-19 publications: Database coverage, citations, readers, tweets, news, Facebook walls, Reddit posts [PDF]

, 2020
© 2020 The Authors. Published by MIT Press. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1162/qss_a_00066The COVID ...
Adie E., Chen Q., Clark F., Colavizza G., Costas R., de Solla Price D., Delwiche F. A., Fairclough R., Gunn W., Harzing A. W., Haustein S., Haustein S., Haustein S., Holmberg K., Ioannidis J. P., Kostoff R. N., Kousha K., Kousha K., Lewison G., Merchant R. M., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Orduña-Malea E., Ortega J. L., Ortega J. L., Ovadia S., Pouris A., Pouris A., Rethlefsen M. L., Robinson-García N., Robinson-García N., Song P., Stegehuis C., Stoddard G., Sud P., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Tian D., Torres-Salinas D., Van Noorden R., Wallace M. L., WHO, Yu H., Zahedi Z., Zahedi Z., Zahedi Z.   +54 more
core   +2 more sources

Molecular Crowding Modulates SARS‐CoV‐2 Aptamer Affinity

Small Structures, 2023
SARS‐CoV‐2 aptamer is a favorable candidate for the recognition and detection of SARS‐CoV‐2, owing to its small size and easy synthesis. However, the issue of compromised binding affinities in real samples and targeting mutant SARS‐CoV‐2 hinder wide ...
Ting Song, Miao Sun, Jialu Zhang, Yinzhu Lu, Shuang Wan, Chaoyong Yang, Yanling Song   +6 more
doaj   +1 more source

Evolutionary Multi-Objective Design of SARS-CoV-2 Protease Inhibitor Candidates

, 2020
Computational drug design based on artificial intelligence is an emerging research area. At the time of writing this paper, the world suffers from an outbreak of the coronavirus SARS-CoV-2.
A Alhossary, CA Lipinski, CA Nicolaou, D Douguet, D Weininger, E van der Horst, E Zitzler, GR Bickerton, H Nguyen, HG Beyer, K Deb, L Zhang, N Brown, N Brown, O Trott, P Ertl, P Ertl, RF de Freitas, RV Devi, SCH Pegg, SS Kaplan, T Gaillard, T Krause, TT Wager, W Dai   +24 more
core   +1 more source

The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses [PDF]

, 2020
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave
Feliciello, Isidoro, Procino, Alfredo
core   +1 more source

Monitoring of SARS‐CoV‐2 infection in mustelids

EFSA Journal, 2021
American mink and ferret are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but no information is available for other mustelid species.
European Food Safety Authority and European Centre for Disease Prevention and Control, Anette Boklund, Christian Gortázar, Paolo Pasquali, Helen Roberts, Søren Saxmose Nielsen, Karl Stahl, Arjan Stegeman, Francesca Baldinelli, Alessandro Broglia, Yves Van Der Stede, Cornelia Adlhoch, Erik Alm, Angeliki Melidou, Grazina Mirinaviciute   +14 more
doaj   +1 more source

Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department [PDF]

, 2020
As of March 30th, 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise.
Brown, Cortlyn, Coralic, Zlatan, Noble, Jeanne   +2 more
core